» Articles » PMID: 35163364

Evaluation of Oxidative Stress Biomarkers, Pro-Inflammatory Cytokines, and Histological Changes in Experimental Hypertension, Dyslipidemia, and Type 1 Diabetes Mellitus

Abstract

The present study aims to compare the oxidative stress biomarkers, pro-inflammatory cytokines, and histological changes induced by three cardiovascular risk factors, namely, hypertension, dyslipidemia, and type 1 diabetes mellitus. Hypertension was induced with 40 mg/kg body weight (b.w.) of N omega-nitro-L-arginine-methyl (L-NAME) administered orally. Dyslipidemia was induced by the administration of a diet with a high cholesterol (2%) content. Diabetes mellitus was induced by intraperitoneal administration of a single dose of streptozocin (65 mg/kg). Malondialdehyde (MDA) and total oxidative status (TOS) are increased by all three cardiovascular risk factors (up to 207%). The indirect assessment of NO synthesis (NOx) is observed to be reduced after L-NAME administration (43%), and dyslipidemia induction (16%), while type 1 diabetes mellitus is associated with the highest levels of NOx (increased 112%). Hypertension, dyslipidemia, and type 1 diabetes reduced the total antioxidative capacity (TAC) and total thiol (SH) levels (up to 57%). The values of evaluated pro-inflammatory cytokines, tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β), assessed from the ascending aorta were elevated by all three cardiovascular risk factors, with the highest levels induced by type 1 diabetes mellitus (up to 259%). The histopathological examination of the ascending and descending aorta revealed reversible pro-atherogenic changes consisting of the accumulation of lipid droplets in the subendothelial connective tissue on rats with hypertension and dyslipidemia. Irreversible pro-atherogenic changes consisting of a reduction of the specific elasticity of the arteries were observed in rats with type 1 diabetes mellitus. Type 1 diabetes mellitus demonstrates an alteration of the oxidative stress parameters, the elevation of tissue levels of the pro-inflammatory cytokines and causing irreversible pro-atherogenic changes on the aortic wall.

Citing Articles

Evaluating the effects of seed oils on lipid profile, inflammatory and oxidative markers, and glycemic control of diabetic and dyslipidemic patients: a systematic review of clinical studies.

Fornari Laurindo L, Fornari Laurindo L, Dogani Rodrigues V, da Silva Camarinha Oliveira J, Leme Boaro B, Cressoni Araujo A Front Nutr. 2025; 12:1502815.

PMID: 39996006 PMC: 11849496. DOI: 10.3389/fnut.2025.1502815.


Threshold effect of non-high-density lipoprotein to high-density lipoprotein cholesterol ratio and hypertension in U.S. adults: NHANES 2005-2016.

Sha Y, Cai Y, Zeng Y, Fu J Medicine (Baltimore). 2025; 104(8):e41585.

PMID: 39993081 PMC: 11856892. DOI: 10.1097/MD.0000000000041585.


Antioxidant and Anti-Inflammatory Effects of Bioactive Compounds in Atherosclerosis.

Rosian S, Boarescu I, Boarescu P Int J Mol Sci. 2025; 26(3).

PMID: 39941147 PMC: 11818840. DOI: 10.3390/ijms26031379.


Mendelian Randomization Study on hs-CRP and Dyslipidemia in Koreans: Identification of Novel SNP rs76400217.

Huang X, Han Y, Kim M Int J Mol Sci. 2025; 26(2).

PMID: 39859220 PMC: 11764716. DOI: 10.3390/ijms26020506.


Predictive markers of early endothelial dysregulation in type-1 diabetes: a meta-analysis.

Mathai M, Alshawsh M, Zulli A, Ranasinghe R Acta Diabetol. 2024; .

PMID: 39527296 DOI: 10.1007/s00592-024-02401-2.


References
1.
Fatkhullina A, Peshkova I, Koltsova E . The Role of Cytokines in the Development of Atherosclerosis. Biochemistry (Mosc). 2016; 81(11):1358-1370. PMC: 5471837. DOI: 10.1134/S0006297916110134. View

2.
Harisa G, Attia S, Zoheir K, Alanazi F . Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte's arginase activation. Saudi Pharm J. 2017; 25(1):120-127. PMC: 5310152. DOI: 10.1016/j.jsps.2016.05.007. View

3.
Pechanova O, Matuskova J, Capikova D, Jendekova L, Paulis L, Simko F . Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats. Kidney Int. 2006; 70(1):170-6. DOI: 10.1038/sj.ki.5001513. View

4.
Kacar S, Kar F, Hacioglu C, Kanbak G, Sahinturk V . The effects of L-NAME on DU145 human prostate cancer cell line: A cytotoxicity-based study. Hum Exp Toxicol. 2019; 39(2):182-193. DOI: 10.1177/0960327119880591. View

5.
Liu I, Chang C, Juang S, Kou D, Tong Y, Cheng K . Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats. Int J Exp Pathol. 2008; 89(4):292-300. PMC: 2525777. DOI: 10.1111/j.1365-2613.2008.00595.x. View